keep
studi
although
recent
report
shah
et
al
demonstr
occur
summari
show
dhplc
detect
previous
character
novel
mutat
associ
acquir
resist
imatinib
pcr
product
analysi
perform
less
min
autom
instrument
platform
increas
sensit
direct
sequenc
method
consider
reduc
labor
consum
cost
sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
novel
sarsassoci
coronaviru
cov
identifi
caus
agent
reliabl
sensit
determin
sar
cov
load
would
aid
earli
identif
infect
individu
provid
guidanc
treatment
especi
use
steroid
hormon
antivir
agent
aid
monitor
patient
clinic
cours
outcom
among
avail
test
viral
gene
amplif
revers
transcriptionpcr
rtpcr
provid
rel
rapid
specif
test
diagnosi
individu
show
sarsassoci
symptom
rtpcr
success
use
detect
sar
cov
nasopharyng
aspir
nasopharyng
swab
throat
swab
broncheoalveolar
lavag
sar
patient
howev
composit
sampl
vari
time
among
individu
unlik
serv
standard
sampl
sourc
quantif
comparison
monitor
sar
cov
infect
meet
clinic
need
improv
rtpcr
method
develop
plasma
use
sampl
sourc
consist
plasma
composit
make
good
sampl
sourc
monitor
cov
load
covenrich
sampl
critic
achiev
high
detect
rate
current
method
limit
detect
window
larg
fulli
util
cov
viral
rna
sampl
high
falseclin
chemistri
neg
rate
current
method
unabl
definit
rule
sar
within
day
onset
increas
viral
rna
input
could
enhanc
chanc
detect
cov
input
pcr
increas
reduc
loss
cov
sampl
prepar
increas
amount
prepar
cov
rna
cdna
product
use
final
pcr
amplif
high
input
cov
sampl
may
increas
detect
rate
guid
concept
made
follow
modif
previous
report
realtim
quantit
rtpcr
cov
instead
use
rna
captur
column
use
trizol
extract
total
rna
increas
yield
cov
sampl
b
instead
use
total
obtain
cov
rna
revers
transcript
step
dri
whole
trizolextract
cov
rna
sampl
di
solv
revers
transcript
reaction
mixtur
use
revers
transcript
step
c
instead
take
revers
transcript
product
pcr
amplif
use
revers
transcript
product
addit
ensur
effici
nest
anneal
pcr
primer
perform
revers
transcript
cov
sequencespecif
primer
extend
nucleotid
beyond
pcr
primer
sequenc
make
modif
abl
achiev
detect
rate
determin
test
sampl
sar
patient
admit
hospit
diagnos
accord
definit
sar
outbreak
march
june
among
male
femal
age
year
mean
age
year
patient
awar
will
particip
test
detail
descript
patient
method
pleas
see
data
supplement
accompani
onlin
version
technic
brief
http
addit
fals
posit
detect
method
assess
sampl
patient
infect
virus
furthermor
plasma
sar
patient
test
four
time
yield
mean
cov
load
ml
plasma
interassay
cv
main
goal
establish
method
monitor
cov
load
clinic
cours
first
examin
cov
load
sar
patient
differ
sar
stage
classifi
three
group
group
day
fever
onset
n
patient
group
day
fever
onset
n
patient
group
day
fever
onset
n
patient
data
fig
indic
mean
cov
copi
number
patient
day
fever
onset
group
ml
plasma
patient
cov
load
substanti
copi
could
easili
detect
modifi
method
patient
beyond
day
onset
group
mean
cov
copi
number
decreas
dramat
ml
plasma
data
impli
follow
peak
shed
cov
correspond
peak
cours
sar
viru
highest
transmiss
potenti
consist
epidemiolog
data
b
residu
sar
cov
may
persist
patient
circul
rel
long
time
without
obviou
effect
host
pathophysiolog
signific
detect
residu
cov
load
last
month
clear
attent
paid
phenomenon
c
develop
sar
test
import
take
account
time
sampl
collect
evalu
sensit
detect
rate
final
procedur
detect
abund
cov
firstweek
sampl
unlik
effect
earli
diagnosi
monitor
therapeut
effect
detect
subclin
sar
cov
infect
improv
method
detect
presenc
copi
cov
high
detect
rate
firstweek
sampl
notabl
number
cov
copi
detect
acutephas
patient
day
fever
onset
method
much
higher
valu
report
elsewher
may
attribut
differ
sever
patient
infect
differ
sampl
input
three
step
cov
mrna
extract
cov
cdna
product
pcr
amplif
small
differ
sampl
input
step
could
lead
larg
differ
final
cov
copi
number
amplif
enzym
reaction
next
test
whether
improv
method
could
use
monitor
chang
cov
load
individu
sar
patient
method
could
detect
cov
load
sar
cours
demonstr
fig
repres
data
patient
test
wherea
patient
sharp
decreas
cov
titer
patient
b
maintain
high
cov
titer
reflect
individu
differ
sar
cours
dynam
chang
cov
concentr
patient
circul
provid
guidanc
therapeut
intervent
especi
adjust
dose
prednisolon
ribavirin
anoth
way
increas
cov
sampl
input
enhanc
cov
detect
use
sampl
origin
enrich
cov
sar
cov
rna
viru
target
cell
use
cellular
machineri
replic
addit
epitheli
cell
line
respiratori
tract
target
cov
lymphocyt
also
highli
like
target
cov
lymphopenia
occur
almost
sar
patient
therefor
separ
lymphocyt
ml
blood
ficol
extract
total
rna
lymphocyt
use
recov
rna
modifi
quantit
method
cov
although
lymphocyt
plasma
healthi
individu
patient
influenza
viral
infect
eg
mump
rubella
detect
cov
high
concentr
cov
found
lymphocyt
patient
test
day
fever
onset
patient
recov
sar
one
four
order
magnitud
higher
concentr
measur
ml
plasma
patient
fig
c
find
provid
evid
lymphocyt
target
reservoir
sar
cov
better
sampl
sourc
plasma
detect
sar
cov
conclus
believ
use
lymphocyt
highli
enrich
cov
standard
simpl
ficol
separ
make
propos
method
suitabl
detect
monitor
sarscov
diagnosi
iron
defici
id
function
iron
defici
fid
particularli
challeng
patient
acut
chronic
inflammatori
condit
biochem
marker
iron
metabol
affect
acutephas
respons
apr
hemoglobin
content
reticulocyt
chr
earli
sensit
indic
fid
recent
present
novel
approach
provid
insight
diagnosi
fid
apr
use
chr
id
fid
defin
chr
pg
base
distribut
chr
biochem
marker
iron
statu
healthi
control
chr
pg
use
identif
id
fid
anem
patient
valu
ferritin
solubl
transferrin
receptor
stfr
stfrf
index
stfr
log
ferritin
perform
significantli
better
patient
without
apr
base
creactiv
protein
crp
cutoff
mgl
id
combin
inflamm
cutoff
valu
stfrf
index
simpl
id
diagnost
plot
develop
combin
chr
stfrf
index
allow
identif
four
major
categori
id
iron
replet
normal
erythropoiesi
b
patient
reduc
iron
suppli
yet
irondefici
erythropoiet
state
c
deplet
storag
function
iron
decreas
hemoglobin
erythrocyt
classic
id
fid
ironreplet
state
decreas
hemoglobin
erythrocyt
plot
provid
use
approach
diagnosi
irondefici
state
date
measur
reticulocyt
hemoglobin
restrict
analyz
singl
manufactur
second
manufactur
produc
would
appear
compar
index
socal
reti
gener
sysmex
analyz
reti
mean
valu
forwardscatteredlight
histogram
within
reticulocyt
popul
correspond
valu
rbci
mean
valu
forwardscatteredlight
histogram
within
matur
erythrocyt
popul
preliminari
studi
see
demonstr
good
correl
rbci
mean
cell
hemoglobin
mch
better
fact
mean
cell
volum
mcv
mathemat
transform
appli
rbci
therefor
produc
hemoglobin
equival
erythrocyt
rbch
e
express
picogram
appli
transform
reti
give
reticulocyt
hemoglobin
equival
express
picogram
appropri
name
index
would
reticulocyt
hemoglobin
equival
reth
e
object
studi
twofold
establish
diagnost
equival
reti
reth
e
chr
b
describ
clinic
assess
diagnost
plot
combin
reti
stfrf
index
tool
diagnosi
therapeut
monitor
ironrestrict
erythropoiesi
period
studi
adult
anem
patient
men
women
hemoglobin
gl
men
gl
women
specimen
collect
complet
blood
cell
count
chr
reti
stfr
ferritin
crp
within
h
admiss
patient
diagnos
includ
cancerrel
anemia
anemia
endstag
renal
failur
anemia
inflammatori
disord
anemia
pregnanc
anemia
heterogen
origin
blood
count
perform
advia
bayer
diagnost
sysmex
sysmex
corpor
autom
hematolog
analyz
reticulocyt
channel
sysmex
sampl
stain
polymethin
dye
specif
rnadna
analyz
flow
cytometri
use
semiconductor
laser
twodimension
distribut
forwardscatt
light
fluoresc
present
scattergram
indic
matur
erythrocyt
reticulocyt
reti
mean
valu
forwardscatteredlight
histogram
